BRIM Biotechnology, Inc.
↗Taipei, Taiwan
BRIM Biotechnology is a clinical-stage biopharmaceutical company focused on developing first-in-class regenerative therapies for ophthalmology and degenerative joint diseases. The company utilizes its proprietary Pigment Epithelium-Derived Factor (PEDF)-derived Short Peptide (PDSP) technology platform to stimulate stem cell proliferation and tissue repair.
BRIM operates using an efficient translational science model, bridging the gap between early research and clinical proof-of-concept. Headquartered in Taiwan, the company maintains a virtual and collaborative R&D approach, partnering with global CROs and academic institutions to advance its pipeline toward commercialization.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$0M-$5M
Founded:2013
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$85M+
Investors:Affinity Capital, Grand Pharmaceutical Group, Industrial Technology Research Institute (ITRI)
STOCK
Exchange:TWSE
Ticker:6885
Market Cap:$125M
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (BRM421)
Modalities:Regenerative Peptides, Small molecule, Stem Cell (via spin-offs)
Active Trials:4
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Ascendo Biotechnology (Spin-off)
Key Partnerships:Grand Pharmaceutical (China licensing rights for BRM421), ITRI (Industrial Technology Research Institute) for glaucoma assets
COMPETITION
Position:Niche Player
Competitors:AbbVie (Restasis), Novartis (Xiidra), Kala Pharmaceuticals, Bausch + Lomb
LEADERSHIP
Key Executives:
Andrew Lin - Chairman
Dr. Wen-Chyi Shyu - CEO
Scientific Founders:Dr. Haishan Jang, Dr. Frank Lee
Board Members:Andrew Lin, Dr. Haishan Jang, Audrey Tseng, Dr. Johnsee Lee (Independent)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BRIM Biotechnology, Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.